-
Conceptual Framework for Addressing Residual Atherosclerotic Cardiovascular Disease Risk in the Era of Precision MedicinePatel KV, Pandey A, de Lemos JA et al. -
Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS TrialFox KAA, Eikelboom JW, Yusuf S et al.
-
Inhibition of Platelet Aggregation After Coronary Stenting in Patients Receiving Oral AnticoagulationC Genz, RC Braun-Dullaeus.
-
Polymer-based or Polymer-free Stents in Patients at High Bleeding RiskS Windecker, A Latib, the ONYX ONE Investigators et al.
-
A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor SignalingBAT Rodriguez, A Bhan, A Beswick et al.
-
Rationale and design of the comparison between a P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients undergoing implantation of coronary drug-eluting stents (SMART-CHOICE): A prospective multicenter randomized trialSong YB, Gwon HC, Hahn JY et al.
-
Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registrySahlén A, Varenhorst C, Lagerqvist B et al.
-
Ticagrelor With or Without Aspirin After Complex PCIG Dangas, U Baber, R Mehran et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
